PineTree Therapeutics Inc

PineTree Therapeutics is a biotechnology startup headquartered in Cambridge, Massachusetts, focused on developing next-generation targeted protein degraders (TPDs) to combat drug resistance in oncology and other therapeutic areas. Their proprietary AbReptor™ platform utilizes bispecific antibodies to degrade membrane-bound and extracellular proteins, offering a novel approach to address treatment-resistant diseases. The company has a robust preclinical pipeline of TPD candidates for oncology and other indications, demonstrating its commitment to advancing innovative therapies.

Pinetree has garnered significant funding through Series A and A1 rounds, which are being used to further develop their AbReptor™ platform and advance their pipeline of TPD candidates. They have already established a global partnership with AstraZeneca for an EGFR degrader candidate, showcasing the potential of their technology and attracting attention from leading pharmaceutical companies. PineTree's focus on overcoming drug resistance and their innovative approach to TPD development make them a promising player in the biotechnology landscape.

PineTree Therapeutics offers a competitive compensation package that includes medical and dental insurance, paid time off, and a 401(k) plan with a generous company match. They are committed to creating a collaborative and supportive work environment where employees can thrive and develop their careers.

PineTree Therapeutics is a biotech startup developing bispecific antibodies to combat drug-resistant cancers and immune disorders. Their mission is to deliver on the promise of therapeutic antibodies, creating the next generation of transformative medicines for patients by leveraging the power of the immune system. They aim to improve patient care through their innovative research and development of targeted protein degraders.

PineTree Therapeutics promotes a collaborative, supportive, and inclusive work environment that fosters innovation and encourages career growth. The company values teamwork and emphasizes a multidisciplinary approach to research and development. Their goal is to create a dynamic startup environment where employees are empowered to contribute to groundbreaking research and make a transformative impact on the industry.

PineTree Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace. They strive to create a culture where all employees feel valued, respected, and empowered to contribute their unique talents and perspectives. Their commitment to DEI is reflected in their recruitment and hiring practices, their employee development programs, and their overall company culture. They actively seek out candidates from underrepresented groups and provide opportunities for professional growth and advancement. PineTree believes that diversity of thought and experience leads to better science, stronger innovation, and a more positive and productive work environment.